<DOC>
	<DOC>NCT02869165</DOC>
	<brief_summary>A randomized controlled trial looking at the effects of vaginal estrogen and a nonhormonal alternative on the vaginal and urinary microbiome in women with genitourinary syndrome of menopause.</brief_summary>
	<brief_title>Vaginal and Urinary Microbiome Trial</brief_title>
	<detailed_description>This is a study is looking at the effects of vaginal estrogen and a nonhormonal alternative on the vaginal and urinary microbiome in women with genitourinary syndrome of menopause with the primary objective is to describe the bacterial communities associated in the vagina and urine of postmenopausal women receiving treatment for genitourinary syndrome of menopause with Premarin® vaginal cream and a nonhormonal alternative, such as, apricot kernel oil. The participants will be randomized to either Premarin vaginal cream or apricot kernel oil. They will be given validated questionnaires to assess their urinary and vaginal symptoms, sexual function, quality of life, and impressions of severity and improvement.</detailed_description>
	<mesh_term>Urinary Tract Infections</mesh_term>
	<mesh_term>Vaginitis</mesh_term>
	<mesh_term>Atrophic Vaginitis</mesh_term>
	<mesh_term>Estrogens, Conjugated (USP)</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<criteria>Age 18years old Women who qualify for vaginal estrogen Suitability for followup Age &lt; 18years old Known allergic reaction or other adverse reactions to Premarin® or any of its components or apricot kernel oil. Inability to apply the treatment as indicated because of other limitations. Already using another form of vaginal estrogen or apricot kernel oil other nonhormonal vaginal moisturizer in the past two weeks. Known active vaginal infection (symptomatic and/or untreated) or completion of treatment for bacterial vaginosis or cervical/vaginal infection within one week of recruitment. History of recurrent or chronic bacterial vaginosis with &gt; 2 episodes per year or symptoms reported for &gt; 6 months out of the last year. History of active vaginal ulcerative disease (active ulcers from atrophy, herpes symptoms at recruitment or herpes with &gt;2 outbreaks per year or last outbreak &lt;1month ago. Chronic antibiotic or probiotic use for indications not listed. Pelvic organ prolapse beyond the hymenal ring. Using a vaginal pessary , vaginal hormonal ring, or indwelling urinary catheter Evidence of active urinary tract infection by history and symptoms, urine dipstick or urine culture on day of presentation or within last 2 weeks. Recurrent or chronic bacterial vaginosis or recurrent or chronic urinary tract infection 3 episodes with the last year or 2 episodes within the last 6 months. History of deep venous thrombosis or pulmonary embolism or genetic predisposition to thromboembolism. History of an estrogen dependent cancer. Vaginal mesh erosion. Active vulvar dermatoses and on chronic topical steroids. Inability to speak or read English.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Postmenopausal</keyword>
</DOC>